4.6 Review

Leptin as an immunomodulator

Journal

MOLECULAR ASPECTS OF MEDICINE
Volume 33, Issue 1, Pages 35-45

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.mam.2011.10.012

Keywords

Leptin; Autoimmunity; Inflammation; Infection diseases; Metabolism

Funding

  1. EU
  2. ERC [202579]
  3. Telethon-JDRF [GJT08004]
  4. FISM [2009/R/26]
  5. European Research Council (ERC) [202579] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Leptin is an adipocyte-derived hormone/cytokine that links nutritional status with neuroendocrine and immune functions. In humans, leptin influences energy homeostasis and regulates neuroendocrine function primarily in states of energy deficiency. Initially described as an antiobesity hormone, leptin has subsequently been shown also to influence basal metabolism, hematopoiesis, thermogenesis, reproduction, and angiogenesis. As a cytokine, leptin can affect thymic homeostasis and the secretion of acute-phase reactants such as interleukin-1 (IL-1) and tumor-necrosis factor-alpha (TNF-alpha). Leptin links nutritional status and proinflammatory T helper 1 (Th1) immune responses ani the decrease in leptin plasma concentration during food deprivation leads to impaired immune function. Similar to other pro-inflammatory cytokines, leptin promotes Th1-cell differentiation and can modulate the onset and progression of autoimmune responses in several animal models of disease. Here, we review the advances and controversy for a role of leptin in the pathophysiology of immune responses and discuss novel possible therapeutic implications for leptin modulators. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available